|
Introduction
Safety, Efficacy and Quality of medicines has been a
concern since ages. Falsified medicines have been cited
in documents dating back to the fourth century BC, and
the problem of counterfeit drugs has persisted since
then.1
Counterfeit medicine is defined differently by drug
regulatory authorities of the globe. The United States
Federal Food, Drug and Cosmetic Act’ defines counterfeit
drug as a drug which, or the container or labeling of
which, without authorization, bears the trademark, trade
name, or other identifying mark, imprint, or device, or
any likeness thereof, of a drug manufacturer, processor,
packer, or distributor other than the person or persons
who in fact manufactured, processed, packed, or
distributed such drug and which thereby falsely purports
or is represented to be the product of, or to have been
packed or distributed by, such other drug manufacturer,
processor, packer, or distributor..
For full text of this article contact the publisher on
info@kppub.com
|
The above content is an
abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate,
New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email:
info@kppub.com /
fpc@vsnl.com, Website:
http://www.kppub.com |
